Showing results (11-20 of 217) with videos related to
Sort By:
Pageof 22
Clinical Pharmacology and Therapeutics|November 15, 2008
Adolescents in clinical trialsB G Kapogiannis, D R MattisonLancet (London, England)|January 28, 1978
Smoking and industrial pollution, and their effects on menopause and ovarian cancerD R Mattison, S S ThorgeirssonToxicology and Applied Pharmacology|March 1, 1991
Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamideD R Plowchalk, D R MattisonAmerican Journal of Industrial Medicine|January 1, 1987
Experimental and clinical studies on the reproductive toxicology of 2,3,7,8-tetrachlorodibenzo-p-dioxinE K Silbergeld, D R MattisonReproductive Toxicology (Elmsford, N.Y.)|January 1, 1992
Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and functionD R Plowchalk, D R MattisonRisk Analysis : an Official Publication of the Society for Risk Analysis|August 1, 1994
Summary of the workshop on issues in risk assessment: quantitative methods for developmental toxicologyD R Mattison, J D SandlerPediatric Pharmacology (New York, N.Y.)|January 1, 1982
Oocyte destruction by polycyclic aromatic hydrocarbons is not linked to the inducibility of ovarian aryl hydrocarbon (benzo(a)pyrene) hydroxylase activity in (DBA/2N X C57BL/6N) F1 X DBA/2N backcross miceD R Mattison, M S NightingaleJournal of Medical Primatology|January 1, 1983
Development of a nonhuman primate model for fetoscopyD R Mattison, J C KingThe Anatomical Record|April 1, 1979
Degeneration of mouse oocytes in response to polycyclic aromatic hydrocarbonsB J Gulyas, D R MattisonGynecologic and Obstetric Investigation|January 1, 1991
Oxytocin pharmacodynamics: effect of long infusions on uterine activityH D Crall, D R MattisonPageof 22